Cosmo Pharmaceuticals
Italian (born 1964), Chief Operating Officer since January 2021, Mr. Lecchi has been with Cosmo since 2001 and served as Deputy CFO since 2007 prior to his appointment as Head of Internal Audit in 2016. From 1992 to 1999 he worked at an international audit firm. From 1999-2001 he was the Director of Administration at Gianfranco Ferrè S.p.A. and its subsidiary GF Manufacturing S.r.l. He graduated in Economics and Business Administration specializing in financial administration at the Bocconi University in Milan. In 1999 he was admitted to the Official Register of Public Auditors.
This person is not in any offices
Cosmo Pharmaceuticals
Cosmo is a specialty pharmaceutical company with a focus on gastroenterology and endoscopy. They develop and manufacture products which are distributed globally. The company’s proprietary clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases, specifically Inflammatory Bowel Diseases (IBD), colon infections and colon diagnosis.